Teupolioside and Graminex (Xipag®) combined therapy induced anti-inflammatory effects and decreased dihydrotestosterone levels in the prostate tissue of patients with benign prostate hyperplasia: results of a pilot study
{{output}}
Background: Teupolioside effectively reduced hirsutism in policystic ovary sindrome by lowering hormonal levels, thus suggesting potential for benign prostatic hyperplasia (BPH) treatment. This study will assess Dihydrotestostero... ...
